BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 28460338)

  • 1. Iron overload promotes erythroid apoptosis through regulating HIF-1a/ROS signaling pathway in patients with myelodysplastic syndrome.
    Zheng QQ; Zhao YS; Guo J; Zhao SD; Song LX; Fei CM; Zhang Z; Li X; Chang CK
    Leuk Res; 2017 Jul; 58():55-62. PubMed ID: 28460338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of APAF-1 elevates erythroid apoptosis in iron overload myelodysplastic syndrome.
    Gu S; Zhao Y; Guo J; Xu F; Fei C; Zhang X; Xiao C; Chang C; Li X
    Tumour Biol; 2014 Mar; 35(3):2211-8. PubMed ID: 24142530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron overload may promote alteration of NK cells and hematopoietic stem/progenitor cells by JNK and P38 pathway in myelodysplastic syndromes.
    Hua Y; Wang C; Jiang H; Wang Y; Liu C; Li L; Liu H; Shao Z; Fu R
    Int J Hematol; 2017 Aug; 106(2):248-257. PubMed ID: 28405919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron overload regulate the cytokine of mesenchymal stromal cells through ROS/HIF-1α pathway in Myelodysplastic syndromes.
    Hu J; Meng F; Hu X; Huang L; Liu H; Liu Z; Li L
    Leuk Res; 2020 Apr; 93():106354. PubMed ID: 32380365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactive oxygen species mediated T lymphocyte abnormalities in an iron-overloaded mouse model and iron-overloaded patients with myelodysplastic syndromes.
    Chen J; Lu WY; Zhao MF; Cao XL; Jiang YY; Jin X; Xu P; Yuan TT; Zhang YC; Chai X; Meng JX; Li Q; Xiao X; Mu J; Li DG; Qi AP
    Ann Hematol; 2017 Jul; 96(7):1085-1095. PubMed ID: 28421266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular ROS profile in hematopoietic progenitors of MDS patients: association with blast count and iron overload.
    Chan LSA; Gu LC; Leitch HA; Wells RA
    Hematology; 2021 Dec; 26(1):88-95. PubMed ID: 34000978
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of iron overload by transfusion on survival and leukemia transformation of myelodysplastic syndromes in a single center of China.
    Wang Y; Huang L; Hua Y; Liu H; Jiang H; Wang H; Zhang W; Fu R; Shao Z
    Hematology; 2021 Dec; 26(1):874-880. PubMed ID: 34753406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron overload impairs normal hematopoietic stem and progenitor cells through reactive oxygen species and shortens survival in myelodysplastic syndrome mice.
    Jin X; He X; Cao X; Xu P; Xing Y; Sui S; Wang L; Meng J; Lu W; Cui R; Ni H; Zhao M
    Haematologica; 2018 Oct; 103(10):1627-1634. PubMed ID: 29903757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemorrhagic risk due to platelet dysfunction in myelodysplastic patients, correlations with anemia severity and iron overload.
    Popov VM; Vladareanu AM; Bumbea H; Kovacs E; Savopol T; Iordache MM; Moisescu MG
    Blood Coagul Fibrinolysis; 2015 Oct; 26(7):743-9. PubMed ID: 25811447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron overload impairs proliferation of erythroid progenitors cells (BFU-E) from patients with myelodysplastic syndromes.
    Hartmann J; Braulke F; Sinzig U; Wulf G; Maas JH; Konietschke F; Haase D
    Leuk Res; 2013 Mar; 37(3):327-32. PubMed ID: 23259989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of HIF-1a could partially protect K562 cells from 1,4-benzoquinone induced toxicity by inhibiting ROS, apoptosis and enhancing glycolysis.
    Sun R; Meng X; Pu Y; Sun F; Man Z; Zhang J; Yin L; Pu Y
    Toxicol In Vitro; 2019 Mar; 55():18-23. PubMed ID: 30448556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unraveling the mechanisms behind iron overload and ineffective hematopoiesis in myelodysplastic syndromes.
    Angelucci E; Cianciulli P; Finelli C; Mecucci C; Voso MT; Tura S
    Leuk Res; 2017 Nov; 62():108-115. PubMed ID: 29054020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxymatrine suppresses proliferation and induces apoptosis of hemangioma cells through inhibition of HIF-1a signaling.
    Fei ZW; Qiu MK; Qi XQ; Dai YX; Wang SQ; Quan ZW; Liu YB; Ou JM
    Int J Immunopathol Pharmacol; 2015 Jun; 28(2):201-8. PubMed ID: 25816398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of iron chelation therapy on EPO-STAT5 signalling pathway and EPO resistance in iron-overloaded low-risk myelodysplastic syndrome patients.
    Zhang Y
    Hematology; 2020 Dec; 25(1):1-10. PubMed ID: 31838956
    [No Abstract]   [Full Text] [Related]  

  • 15. Iron overload and chelation therapy in myelodysplastic syndromes.
    Temraz S; Santini V; Musallam K; Taher A
    Crit Rev Oncol Hematol; 2014 Jul; 91(1):64-73. PubMed ID: 24529413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron overload induced by ferric ammonium citrate triggers reactive oxygen species-mediated apoptosis via both extrinsic and intrinsic pathways in human hepatic cells.
    Li SW; Liu CM; Guo J; Marcondes AM; Deeg J; Li X; Guan F
    Hum Exp Toxicol; 2016 Jun; 35(6):598-607. PubMed ID: 26224043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron overload alters the energy metabolism in patients with myelodysplastic syndromes: results from the multicenter FISM BIOFER study.
    Cilloni D; Ravera S; Calabrese C; Gaidano V; Niscola P; Balleari E; Gallo D; Petiti J; Signorino E; Rosso V; Panuzzo C; Sabatini F; Andreani G; Dragani M; Finelli C; Poloni A; Crugnola M; Voso MT; Fenu S; Pelizzari A; Santini V; Saglio G; Podestà M; Frassoni F
    Sci Rep; 2020 Jun; 10(1):9156. PubMed ID: 32514107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The TNF-α/ROS/HIF-1-induced upregulation of FoxMI expression promotes HCC proliferation and resistance to apoptosis.
    Xia L; Mo P; Huang W; Zhang L; Wang Y; Zhu H; Tian D; Liu J; Chen Z; Zhang Y; Chen Z; Hu H; Fan D; Nie Y; Wu K
    Carcinogenesis; 2012 Nov; 33(11):2250-9. PubMed ID: 22831955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phospholipase C beta1 (PI-PLCbeta1)/Cyclin D3/protein kinase C (PKC) alpha signaling modulation during iron-induced oxidative stress in myelodysplastic syndromes (MDS).
    Cappellini A; Mongiorgi S; Finelli C; Fazio A; Ratti S; Marvi MV; Curti A; Salvestrini V; Pellagatti A; Billi AM; Suh PG; McCubrey JA; Boultwood J; Manzoli L; Cocco L; Follo MY
    FASEB J; 2020 Nov; 34(11):15400-15416. PubMed ID: 32959428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Free iron catalyzes oxidative damage to hematopoietic cells/mesenchymal stem cells in vitro and suppresses hematopoiesis in iron overload patients.
    Lu W; Zhao M; Rajbhandary S; Xie F; Chai X; Mu J; Meng J; Liu Y; Jiang Y; Xu X; Meng A
    Eur J Haematol; 2013 Sep; 91(3):249-261. PubMed ID: 23772810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.